Voyage Foods, the Bay Area food innovation company that combines breakthrough technology and upcycled wholesome ingredients to secure the future of our favorite foods, announces today its first...

Emerson (NYSE: EMR) today announced Chief Operating Officer, Ram Krishnan, and Chief Financial Officer, Mike Baughman, will present at J.P. Morgan's 2024 Industrials Conference on Wednesday, March...

Lockheed Martin (NYSE: LMT) will webcast live a presentation by Chief Financial Officer Jay Malave at the J.P. Morgan Industrials Conference on Wednesday, March 13 at 10:15 a.m. to 10:50 a.m. ET....

Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of smart glasses and Augmented Reality (AR) technology and products, today announced that Moviynt, its wholly...

Innovative thermal containment solution will be showcased at booth 201 at the International Battery Seminar and Exhibit March 12-15 in Orlando, Florida WAXAHACHIE, Texas, March 6, 2024...

ATI Inc. (NYSE: ATI) Chief Financial Officer Don Newman will speak at the 2024 JP Morgan Industrials Conference in New York City, New York, on March 13, 2024 at 12:00 p.m. ET. The link to the...

Reqorsa® Immunogene Therapy May be a Potential Therapy for ALK-Positive Lung Cancer REQORSA has Anti-Tumor Mechanisms that Target and Disrupt the Metabolism of Cancer Cells NPRL2 Gene Therapy...

A total of 29 abstracts, including three late-breaking presentations, demonstrate AbbVie and Allergan Aesthetics' shared commitment to advancing science across a spectrum of immune-mediated...

New data from Futurum1 suggests that the mainframe skills pool is growing, with 65 percent of university leaders surveyed reporting more skilled mainframe talent available today as compared to the...

The TriZetto platform, powered by Azure OpenAI Service, will help payers and providers reduce hidden costs and enable better patient outcomes for millions of Americans. TEANECK, N.J., March 6,...

Quantic ECI, Quantic Ohmega Ticer, Quantic PMI and Quantic TRM to showcase RF and microwave technology solutions in Booth #1438 EAST PROVIDENCE, R.I., March 6, 2024 /PRNewswire/ -- Quantic®...

Native Forward Scholars Fund is the first Native organization to receive the honor in the award's 24-year history. ALBUQUERQUE, N.M., March 6, 2024 /PRNewswire/ -- Native Forward Scholars Fund has...

Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that it will present data from its...

Geneos Therapeutics, a clinical stage biotherapeutics company focused on the development of personalized therapeutic cancer vaccines (PTCV), today announced the upcoming presentation of two...

Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the Barclays 26th Annual Global Healthcare Conference on Wednesday,...

Koya Medical, today announces topline results from its TEAYS trial. TEAYS (NCT05507346) is a prospective multi-center, randomized cross-over study comparing lower extremity lymphedema treatment...

On February 27th, the China Telecom Cloud and Connectivity Summit was successfully held at the grand 2024 Mobile World Congress (MWC2024) in Barcelona. With the theme of " Leading the...

Eli Lilly and Company (NYSE: LLY) today announced that preclinical data for agents targeting Nectin-4, KRAS G12D, and BRM (SMARCA2) will be presented at the American Association for Cancer...

-- Data support ongoing development of antibody-drug conjugate (ADC) program targeting HER3-expressing cancers – -- On-track to nominate development candidate in 2024 -- BOSTON, March 5, 2024...

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that interim...

Preclinical data demonstrate presence of CD161 expressing T cells in anti-PD1 non-responder tumors and enhanced T cell mediated cytotoxicity with combination treatment of IMT-009 and anti-PD1,...

Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for patients with mTOR-driven cancers, today announced poster...

Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage immunology company, today announced it will be providing updates on its RNA immunotherapies at multiple presentations at the American...

-Sapience to present data across its pipeline, including non-clinical immunotherapy results on ST316 and ST101 and preclinical results on its novel AP-1 complex antagonist TARRYTOWN, N.Y., March...

GV20 Therapeutics, a clinical-stage biotechnology company integrating AI, genomics, and disease biology to create next-generation antibody therapeutics for cancer, announced today that its...